UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 769

Sortiert nach

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-10. Hodgkin lymphoma (HL)

International journal of hematology, 2020-02, Vol.111 (2), p.166-179

Nagai, Hirokazu

2020

Volltextzugriff (PDF)

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-10. Hodgkin lymphoma (HL)

International journal of hematology, 2020-02, Vol.111 (2), p.166-179

Nagai, Hirokazu

2020

Volltextzugriff (PDF)

Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial

Cancer science, 2020-12, Vol.111 (12), p.4540-4547

2020

Volltextzugriff (PDF)

Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan

Japanese journal of clinical oncology, 2022-09, Vol.52 (9), p.966-974

2022

Volltextzugriff (PDF)

Revised staging system for malignant lymphoma based on the Lugano classification

Japanese journal of clinical oncology, 2019-10, Vol.49 (10), p.895-900

2019

Volltextzugriff (PDF)

Combined Inhibition of ALK and HDAC Induces Synergistic Cytotoxicity in Neuroblastoma Cell Lines

Anticancer research, 2019-07, Vol.39 (7), p.3579-3584

2019

Volltextzugriff (PDF)

Electrostatic-triggered exothermic antibody adsorption to the cellulose nanoparticles

Analytical biochemistry, 2021-11, Vol.632, p.114337-114337, Article 114337

2021

Volltextzugriff (PDF)

The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry

International journal of hematology, 2019-08, Vol.110 (2), p.244-249

2019

Volltextzugriff (PDF)

Recent advances in Hodgkin lymphoma: interim PET and molecular-targeted therapy

Japanese journal of clinical oncology, 2015-02, Vol.45 (2), p.137-145

Nagai, Hirokazu

2015

Volltextzugriff (PDF)

Safety and antitumor activity of acalabrutinib for relapsed/refractory B‐cell malignancies: A Japanese phase I study

Cancer science, 2021-06, Vol.112 (6), p.2405-2415

2021

Volltextzugriff (PDF)

Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma

International journal of hematology, 2020-12, Vol.112 (6), p.817-824

2020

Volltextzugriff (PDF)

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1906-1914

2009

Volltextzugriff (PDF)

Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study

International journal of hematology, 2020-03, Vol.111 (3), p.434-439

2020

Volltextzugriff (PDF)

Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives

Virchows Archiv : an international journal of pathology, 2023-05, Vol.482 (5), p.929-930

2023

Volltextzugriff (PDF)

High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma

Annals of nuclear medicine, 2020-09, Vol.34 (9), p.643-652

2020

Volltextzugriff (PDF)

Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study)

Japanese journal of clinical oncology, 2023-04, Vol.53 (4), p.349-354

2023

Volltextzugriff (PDF)

Effects of low crystalline carbonate apatite on proliferation and osteoblastic differentiation of human bone marrow cells

Journal of materials science. Materials in medicine, 2015-02, Vol.26 (2), p.99-8, Article 99

2015

Volltextzugriff (PDF)

Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells

Journal of clinical pathology, 2010-12, Vol.63 (12), p.1059-1065

2010

Volltextzugriff (PDF)

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial

Japanese journal of clinical oncology, 2022-05, Vol.52 (6), p.583-588

2022

Volltextzugriff (PDF)

Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study

International journal of hematology, 2022-12, Vol.116 (6), p.911-921

2022

Volltextzugriff (PDF)

Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Cancer science, 2010-09, Vol.101 (9), p.2059-2064

2010

Volltextzugriff (PDF)

Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers

Oral oncology, 2021-09, Vol.120, p.105453, Article 105453

2021

Volltextzugriff (PDF)

Acute Promyelocytic Leukemia and HIV: Case Reports and a Review of the Literature

Internal Medicine, 2019/08/15, Vol.58(16), pp.2387-2391

2019

Volltextzugriff (PDF)

1 – 25 von 769

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(646)
Mit Volltextzugriff
(714)

Publikationsform

Sprache

Englisch
(680)
Japanisch
(262)
Deutsch
(3)
Koreanisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-10. Hodgkin lymphoma (HL)

JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-10. Hodgkin lymphoma (HL)

Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial

Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan

Revised staging system for malignant lymphoma based on the Lugano classification

Combined Inhibition of ALK and HDAC Induces Synergistic Cytotoxicity in Neuroblastoma Cell Lines

Electrostatic-triggered exothermic antibody adsorption to the cellulose nanoparticles

The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry

Recent advances in Hodgkin lymphoma: interim PET and molecular-targeted therapy

Safety and antitumor activity of acalabrutinib for relapsed/refractory B‐cell malignancies: A Japanese phase I study

Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)

Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study

Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives

High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma

Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study)

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results

Effects of low crystalline carbonate apatite on proliferation and osteoblastic differentiation of human bone marrow cells

Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial

Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study

Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers

Acute Promyelocytic Leukemia and HIV: Case Reports and a Review of the Literature

Suchergebnisse filtern